Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
InSite Vision Incorporated (OTCBB: INSV) today reported financial results for the quarter ended June 30, 2013. Revenues for the second quarter of 2013 were $19.2 million compared to $1.8 million for the same period in 2012. Included in the second quarter of 2013 were revenues of $15 million for the sale of the Besivance® royalty rights.
Hey, check out all the engineering jobs. Post your resume today!
